ARTICLE | Clinical News
Juvaris preclinical data
October 11, 2010 7:00 AM UTC
In mouse models of AML, JVRS-100 significantly increased survival vs. untreated controls. Furthermore, mice whose initial leukemia was successfully treated by JVRS-100 survived significantly longer in...